Sharp Sight Group of Eye Hospitals, a Delhi-based eye-care chain that provides world class treatments for eye disorders such as Cataract, Squint, Glaucoma, Paediatric Ophthalmology, announced that it has raised Rs 70 crore in equity funding from InvAscent, a healthcare-focussed private equity firm, according to VCCircle report.
Sharp Sight chief executive officer Deepshika Sharma said in a statement that the eye-care chain would use the funds to strengthen its presence in Tier-II cities and other underserved areas over the next three years.
“The thought process and ideology of InvAscent blended perfectly with our long-term vision. We strongly believe we will be able to leverage their experience to our benefit as they have expertise in backing many single-specialty chains,” Sharma added.
Founded in 1997 by Samir Sud and Kamal B Kapur, Sharp Sight claims to be one of the best eye hospitals in Delhi NCR providing latest ophthalmic treatments at affordable cost. It has seven centres in north India and two in Tajikistan and Nigeria, according to its website.
InvAscent provides growth capital to companies in the pharmaceutical, healthcare and medical-technology industries.
HrNxt.com Newsdesk has researchers and writers with an excellent domain knowledge about the talent ecosystem, and the business environment. The team keeps a tab on the latest happenings in the ecosystem to bring most relevant news and insights for our readers. You can connect with our newsdesk at newsdesk@hrnxt.com.